Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100


Mobile health (mHealth) based medication adherence measurement - a pilot trial using electronic blisters in diabetes patients.

Brath H, Morak J, Kästenbauer T, Modre-Osprian R, Strohner-Kästenbauer H, Schwarz M, Kort W, Schreier G.

Br J Clin Pharmacol. 2013 Sep;76 Suppl 1:47-55. doi: 10.1111/bcp.12184.


Mobilizing your medications: an automated medication reminder application for mobile phones and hypertension medication adherence in a high-risk urban population.

Patel S, Jacobus-Kantor L, Marshall L, Ritchie C, Kaplinski M, Khurana PS, Katz RJ.

J Diabetes Sci Technol. 2013 May 1;7(3):630-9.


Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension.

Natarajan N, Putnam W, Van Aarsen K, Beverley Lawson K, Burge F.

Can Fam Physician. 2013 Feb;59(2):e93-e100.


A mobile health intervention for inner city patients with poorly controlled diabetes: proof-of-concept of the TExT-MED program.

Arora S, Peters AL, Agy C, Menchine M.

Diabetes Technol Ther. 2012 Jun;14(6):492-6. doi: 10.1089/dia.2011.0252.


Feasibility of mHealth and Near Field Communication technology based medication adherence monitoring.

Morak J, Schwarz M, Hayn D, Schreier G.

Conf Proc IEEE Eng Med Biol Soc. 2012;2012:272-5. doi: 10.1109/EMBC.2012.6345922.


Disparities in the use of a mHealth medication adherence promotion intervention for low-income adults with type 2 diabetes.

Nelson LA, Mulvaney SA, Gebretsadik T, Ho YX, Johnson KB, Osborn CY.

J Am Med Inform Assoc. 2016 Jan;23(1):12-8. doi: 10.1093/jamia/ocv082.


Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.

Düsing R, Handrock R, Klebs S, Tousset E, Vrijens B.

J Hypertens. 2009 Apr;27(4):894-901. doi: 10.1097/HJH.0b013e328323f9be.


Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial.

Bogner HR, Morales KH, de Vries HF, Cappola AR.

Ann Fam Med. 2012 Jan-Feb;10(1):15-22. doi: 10.1370/afm.1344.


Trial to examine text message-based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial.

Arora S, Peters AL, Burner E, Lam CN, Menchine M.

Ann Emerg Med. 2014 Jun;63(6):745-54.e6. doi: 10.1016/j.annemergmed.2013.10.012.


Polypharmacy and medication adherence in patients with type 2 diabetes.

Grant RW, Devita NG, Singer DE, Meigs JB.

Diabetes Care. 2003 May;26(5):1408-12.


A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control.

Friedman RH, Kazis LE, Jette A, Smith MB, Stollerman J, Torgerson J, Carey K.

Am J Hypertens. 1996 Apr;9(4 Pt 1):285-92.


Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determinants of adherence (TELEBPMET Study).

Parati G, Omboni S, Compare A, Grossi E, Callus E, Venco A, Destro M, Villa G, Palatini P, Rosei EA, Scalvini S, Taddei S, Manfellotto D, Favale S, De Matteis C, Guglielmi M; TELEBPMET Study Group., Lonati L, Della Rosa F, Tosazzi E, Grandi AM, Maresca AM, Mongiardi C, Mare M, Ricci AR, Cagnoni F, Georgatos J, Besostri V, Ferrari V, Omodeo O, Dorigatti F, Bonso E, Guarnieri C, Muiesan L, Paini A, Stassaldi D, Cinelli A, Bernocchi P, Rocchi S, Magagna A, Ghiadoni L, Del Frate I, Boresi F, Guidi A, Re MA, Pellicciotti L, Florio A, Morani G, Di Lillo S, Ambrosio A, Casciello A, Quaglia M, Forleo C, Ardito MA, Gerunda S, Panunzio M.

Trials. 2013 Jan 23;14:22. doi: 10.1186/1745-6215-14-22.


Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study.

Tiv M, Viel JF, Mauny F, Eschwège E, Weill A, Fournier C, Fagot-Campagna A, Penfornis A.

PLoS One. 2012;7(3):e32412. doi: 10.1371/journal.pone.0032412.


A multifactorial intervention to improve blood pressure control in co-existing diabetes and kidney disease: a feasibility randomized controlled trial.

Williams A, Manias E, Walker R, Gorelik A.

J Adv Nurs. 2012 Nov;68(11):2515-25. doi: 10.1111/j.1365-2648.2012.05950.x.


Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial.

Lin EH, Von Korff M, Ciechanowski P, Peterson D, Ludman EJ, Rutter CM, Oliver M, Young BA, Gensichen J, McGregor M, McCulloch DK, Wagner EH, Katon WJ.

Ann Fam Med. 2012 Jan-Feb;10(1):6-14. doi: 10.1370/afm.1343.


Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes.

Al-Qazaz HKh, Sulaiman SA, Hassali MA, Shafie AA, Sundram S, Al-Nuri R, Saleem F.

Int J Clin Pharm. 2011 Dec;33(6):1028-35. doi: 10.1007/s11096-011-9582-2.


Patient and physician factors associated with adherence to diabetes medications.

Schoenthaler AM, Schwartz BS, Wood C, Stewart WF.

Diabetes Educ. 2012 May-Jun;38(3):397-408. doi: 10.1177/0145721712440333.


Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.

Selak V, Elley CR, Bullen C, Crengle S, Wadham A, Rafter N, Parag V, Harwood M, Doughty RN, Arroll B, Milne RJ, Bramley D, Bryant L, Jackson R, Rodgers A.

BMJ. 2014 May 27;348:g3318. doi: 10.1136/bmj.g3318.


Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients.

Turner BJ, Hollenbeak C, Weiner MG, Ten Have T, Roberts C.

Pharmacoepidemiol Drug Saf. 2009 Aug;18(8):672-81. doi: 10.1002/pds.1766.

Items per page

Supplemental Content

Support Center